Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study

OBJECTIVE: To investigate sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis. METHODS: Patients who had an inadequate response to methotrexate (MTX) with or without biological disease-modifying antirheumatic drugs were randomly divided into two gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubo, Satoshi, Miyazaki, Yusuke, Amano, Koichi, Matsui, Kiyoshi, Kameda, Hideto, Inoue, Yoshino, Nakayamada, Shingo, Ogura, Takehisa, Kaneko, Yuko, Yamaoka, Kunihiro, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152036/
https://www.ncbi.nlm.nih.gov/pubmed/37185309
http://dx.doi.org/10.1136/rmdopen-2023-003029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152036/
https://www.ncbi.nlm.nih.gov/pubmed/37185309
http://dx.doi.org/10.1136/rmdopen-2023-003029

Ejemplares similares